Delivery Order SPE2DB24D9238-SPE2DB25FDRAJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a pharmaceutical supply to support Department of Defense healthcare requirements. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge,...
- The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg, a prescription oncology medication. This firm fixed-price delivery order was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and carries no set-aside designation. The order will be fulfilled and delivered to Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations as a woman-owned small business pharmaceutical...
- On August 7, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, identified as 4569023499, is for 60 tablets of Xtandi 80 mg, an oncology medication. This award was issued without a set-aside designation and carries an ultimate completion date of August 8, 2025. The order represents a single delivery under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 80 mg tablets (60-count units). The contract, which became effective on July 23, 2025, with an ultimate completion date of July 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its...
- On August 1, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg tablets (120-count units). This firm fixed-price delivery order is associated with DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to issue delivery orders for comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order for delivery to Park Ridge, IL. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 4, 2025, and no set-aside designation...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $8,339.18 by the Defense Logistics Agency on July 21, 2025, for the supply of Xtandi 80 mg tablets (60-count units). This delivery order was issued without a set-aside designation and is scheduled for completion by July 22, 2025, with performance taking place at the contractor's Park Ridge facility. The award represents a...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 80 mg tablets (60-count units) under contract number 4569035597. The award, valued at $4,169.59 with a firm fixed-price structure, was executed on August 8, 2025, with an ultimate completion date of August 11, 2025. This delivery order carries no set-aside designation and represents a continuation of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,169.59 by the Defense Logistics Agency (DLA) on July 22, 2025. The contract, which carries no set-aside designation, calls for the delivery of 60 tablets of Xtandi 80 mg, an oncology medication used in cancer treatment. This delivery order represents one of many pharmaceutical supply orders issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,169.59 on August 12, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The Defense Logistics Agency issued this firm fixed-price delivery order under its larger Indefinite Delivery Contract with DMS Pharmaceutical Group, which is valued at $500 million and remains active through November 2026. The contract carries no set-aside...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDRAJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. on September 8, 2025, for 60 tablets of Xtandi 80 mg, an oncology medication. The delivery order is a firm fixed-price contract with a completion date of September 9, 2025, and was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL 60068. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The underlying IDC, known as the SPE2DB program, authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. As a long-standing federal contractor registered in SAM.gov since 2001, DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/8/25 |